earnings
confidence high
sentiment positive
materiality 0.85
LifeStance Q2 revenue up 26% to $435.4M, net income $23.6M, raises FY2026 guidance, announces $100M buyback
LifeStance Health Group, Inc.
- Revenue $435.4M (+26% YoY), net income $23.6M vs loss $3.8M.
- Adjusted EBITDA $66.0M (+94% YoY), margin 15.2% vs 9.8%.
- Clinician base 8,542 (+11% YoY), visit volumes 2.6M (+19%).
- FY2026 revenue guidance raised to $1.685-1.725B, Adjusted EBITDA $215-235M.
- Board approved new $100M share repurchase program, replacing prior $100M program.